1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Cierpicki, T. Otlewski, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 321 647 658 10.1016/S0022-2836(02)00620-4 12206780 NMR structures of two variants of bovine pancreatic trypsin inhibitor (BPTI) reveal unexpected influence of mutations on protein structure and stability. 2002 US Protein Sci. PRCIEI 0795 0961-8368 11 806 819 10.1110/ps.3510102 Analysis of serine proteinase-inhibitor interaction by alanine shaving 2002 10.2210/pdb1ld6/pdb pdb_00001ld6 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 SINGLE WAVELENGTH M 1 1.0 6211.061 PANCREATIC TRYPSIN INHIBITOR T11A, P13A, R17A, I18A, I19A, V34A, G37A, R39A 1 man polymer no no RPDFCLEPPYAGACRAAAARYFYNAKAGLCQTFAYGACAAKRNNFKSAEDCLRTCGGA RPDFCLEPPYAGACRAAAARYFYNAKAGLCQTFAYGACAAKRNNFKSAEDCLRTCGGA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n cattle Bos Escherichia sample 9913 Bos taurus 562 Escherichia coli BL21 (DE3) PLYSS PLASMID PAED4 database_2 pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations 1 0 2002-09-11 1 1 2008-04-28 1 2 2011-07-13 1 3 2021-10-27 _database_2.pdbx_DOI _database_2.pdbx_database_accession _struct_ref_seq_dif.details RCSB Y RCSB 2002-04-08 REL REL Structure was determined based on homonuclear TOCSY/NOESY techniques using automatic assignment in NOAH/DYANA program structures with the lowest energy,target function 58 10 2D TOCSY 2D NOESY DQF-COSY 0 2.9 ambient 298 K simulated annealing, torsion angle dynamics 1 3mM BPTI_8A 90% H2O/10% D2O Delaglio, F.; Grzesiek, S.; Vuister, G.; Zhu, G.; Pfeifer, J.; Bax, A. processing NMRPipe 1.8 Goddard, T.D.; Kneller, D.G. data analysis Sparky 3.95 Guntert, P.; Mumenthaler, C.; Herrmann, T. structure solution DYANA 1.5 Brunger, A.T.; Adams, P.D.; Clore, G.M.; DeLano, W.L., Gros,P.; Grosse-Kunstleve, R.W.; Jiang, J.S.; Kuszewski, J.; Nilges, M.; Pannu, N.S.; Read, R.J.; Rice, L.M.; Simonson, T.; Warren, G.L. refinement CNS 1.0 500 Varian UNITYPLUS 500 Bruker DRX ARG 1 n 1 ARG 1 A PRO 2 n 2 PRO 2 A ASP 3 n 3 ASP 3 A PHE 4 n 4 PHE 4 A CYS 5 n 5 CYS 5 A LEU 6 n 6 LEU 6 A GLU 7 n 7 GLU 7 A PRO 8 n 8 PRO 8 A PRO 9 n 9 PRO 9 A TYR 10 n 10 TYR 10 A ALA 11 n 11 ALA 11 A GLY 12 n 12 GLY 12 A ALA 13 n 13 ALA 13 A CYS 14 n 14 CYS 14 A ARG 15 n 15 ARG 15 A ALA 16 n 16 ALA 16 A ALA 17 n 17 ALA 17 A ALA 18 n 18 ALA 18 A ALA 19 n 19 ALA 19 A ARG 20 n 20 ARG 20 A TYR 21 n 21 TYR 21 A PHE 22 n 22 PHE 22 A TYR 23 n 23 TYR 23 A ASN 24 n 24 ASN 24 A ALA 25 n 25 ALA 25 A LYS 26 n 26 LYS 26 A ALA 27 n 27 ALA 27 A GLY 28 n 28 GLY 28 A LEU 29 n 29 LEU 29 A CYS 30 n 30 CYS 30 A GLN 31 n 31 GLN 31 A THR 32 n 32 THR 32 A PHE 33 n 33 PHE 33 A ALA 34 n 34 ALA 34 A TYR 35 n 35 TYR 35 A GLY 36 n 36 GLY 36 A ALA 37 n 37 ALA 37 A CYS 38 n 38 CYS 38 A ALA 39 n 39 ALA 39 A ALA 40 n 40 ALA 40 A LYS 41 n 41 LYS 41 A ARG 42 n 42 ARG 42 A ASN 43 n 43 ASN 43 A ASN 44 n 44 ASN 44 A PHE 45 n 45 PHE 45 A LYS 46 n 46 LYS 46 A SER 47 n 47 SER 47 A ALA 48 n 48 ALA 48 A GLU 49 n 49 GLU 49 A ASP 50 n 50 ASP 50 A CYS 51 n 51 CYS 51 A LEU 52 n 52 LEU 52 A ARG 53 n 53 ARG 53 A THR 54 n 54 THR 54 A CYS 55 n 55 CYS 55 A GLY 56 n 56 GLY 56 A GLY 57 n 57 GLY 57 A ALA 58 n 58 ALA 58 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N PHE 22 A N PHE 22 A O GLN 31 A O GLN 31 1 A ALA 13 -161.89 97.96 1 A ALA 17 -161.54 44.34 1 A ALA 19 -79.48 45.26 1 A ALA 27 -141.43 -1.94 1 A THR 32 -83.23 31.80 1 A PHE 33 65.48 159.63 1 A TYR 35 43.75 -165.60 2 A ALA 11 -103.97 75.13 2 A ALA 17 -160.49 41.06 2 A ALA 18 -175.79 80.36 2 A ALA 19 -163.40 -55.14 2 A PHE 33 -46.39 106.16 2 A LYS 41 -62.90 -79.03 3 A ARG 15 -154.48 88.41 3 A ALA 17 -159.16 47.05 3 A TYR 35 -64.57 65.05 3 A LYS 41 -60.97 -77.15 4 A PRO 9 -41.46 170.22 4 A ALA 13 -86.67 36.00 4 A ALA 16 64.99 95.47 4 A ALA 17 -162.57 50.94 4 A ALA 19 -165.00 -48.80 4 A ALA 34 -166.07 -159.28 4 A TYR 35 -36.91 140.86 4 A ALA 37 -162.63 91.61 4 A ARG 42 -84.57 -82.76 5 A ALA 13 70.63 35.06 5 A ALA 16 71.69 101.36 5 A ALA 17 -163.02 44.92 5 A ALA 19 -162.64 21.70 5 A ALA 37 -69.74 -178.97 5 A LYS 41 -59.77 -80.78 6 A ARG 15 -160.44 81.53 6 A ALA 17 71.04 62.83 6 A ALA 19 32.42 73.41 6 A LYS 41 91.19 -68.28 7 A ALA 13 56.49 94.75 7 A ALA 16 80.03 90.36 7 A ALA 17 -160.85 64.90 7 A ALA 19 56.59 92.13 7 A TYR 35 -66.64 64.13 7 A LYS 41 -63.78 -75.35 7 A ASN 44 74.00 115.65 8 A PRO 9 -74.94 -162.74 8 A ALA 17 -160.60 60.33 8 A ALA 19 -164.21 -39.67 8 A LYS 41 -62.50 -81.24 8 A THR 54 -80.07 -70.65 9 A ALA 16 67.19 119.14 9 A ALA 17 -161.78 44.70 9 A ALA 18 -68.72 -169.25 9 A ALA 19 47.03 25.52 9 A TYR 35 41.56 -169.90 10 A ALA 16 63.03 130.20 10 A ALA 17 -161.45 45.80 10 A ALA 18 -68.29 -174.08 10 A ALA 34 -168.52 -152.32 10 A TYR 35 -39.51 121.69 10 A LYS 41 -61.16 -71.73 STRUCTURE OF BPTI_8A MUTANT 1 N N A PRO 2 A PRO 2 HELX_P A GLU 7 A GLU 7 5 1 6 A SER 47 A SER 47 HELX_P A CYS 55 A CYS 55 1 2 9 disulf 2.031 A CYS 5 A SG CYS 5 1_555 A CYS 55 A SG CYS 55 1_555 disulf 2.031 A CYS 14 A SG CYS 14 1_555 A CYS 38 A SG CYS 38 1_555 disulf 2.033 A CYS 30 A SG CYS 30 1_555 A CYS 51 A SG CYS 51 1_555 Hydrolase Inhibitor BPTI, Kunitz fold, Hydrolase Inhibitor BPT1_BOVIN UNP 1 36 P00974 RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGCRAKRNNFKSAEDCMRTCGGA 36 93 1LD6 1 58 P00974 A 1 1 58 1 THR engineered mutation ALA 11 1LD6 A P00974 UNP 46 11 1 PRO engineered mutation ALA 13 1LD6 A P00974 UNP 48 13 1 LYS conflict ARG 15 1LD6 A P00974 UNP 50 15 1 ARG engineered mutation ALA 17 1LD6 A P00974 UNP 52 17 1 ILE engineered mutation ALA 18 1LD6 A P00974 UNP 53 18 1 ILE engineered mutation ALA 19 1LD6 A P00974 UNP 54 19 1 VAL engineered mutation ALA 34 1LD6 A P00974 UNP 69 34 1 GLY engineered mutation ALA 37 1LD6 A P00974 UNP 72 37 1 ARG engineered mutation ALA 39 1LD6 A P00974 UNP 74 39 1 MET conflict LEU 52 1LD6 A P00974 UNP 87 52 2 anti-parallel A PHE 22 A PHE 22 A TYR 23 A TYR 23 A CYS 30 A CYS 30 A GLN 31 A GLN 31